Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Red Hat

The open source software company is scheduled to report its fourth-quarter results on Wednesday. Analysts, on average, anticipate earnings of 27 cents a share on revenue of $291.22 million.

Shares of Red Hat hit a 52-week high Tuesday of $54.01. The stock's 52-week low of $31.77 was set on Aug. 19.

Red Hat shares trade at a forward P/E of 45.7X; the average for software companies is 30.91X. For comparison, Intuit ( INTU) has a lower forward P/E of 17.56X.

Fifteen of the 23 analysts who cover Red Hat rate it at buy. Seven analysts give the stock a hold rating and one rates it at sell.

TheStreet Ratings gives Red Hat a B grade with a buy rating and $59.53 price target. The stock has risen 26.79% so far in 2012.

Analyst comment:

"Red Hat is scheduled to report its F4Q12 earnings after market close on 28th March 2012," Deutsche Bank analysts wrote in a report Monday. "We expect Revenues/EPS of $291m/ $0.27 compared to street estimates of $291m/$0.27. We expect billings to grow 22% y/y. However, we believe the buy side expectations are much higher, given the strong rebound in the stock to reach an all-time high after it had traded off following the billings miss in the previous quarter. Demand trends continue to be stable and we expect RHT to deliver an in-line quarter. Maintain HOLD and $48 PT."


Hitachi

Shares of Hitachi hit a 52-week high of $63.51. The stock's 52-week low of $46.91 was set on Oct. 4.

Hitachi shares trade at a forward P/E of 11.1; the average for electronic equipment companies is 13.6X.

Analysts were split on Hitachi with one rated it a buy and one rating it sell.

TheStreet Ratings gives Hitachi a C+ grade and hold rating. The stock has risen 21.61% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

-- Written by Alexandra Zendrian in New York.

>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to: tips@thestreet.com.

>To follow the writer on Twitter, go to Alexandra Zendrian.

If you liked this article you might like

Former Dendreon CEO Mitch Gold Returns to Public Biotech Stage with Cancer Immunotherapy Merger

These 5 Stocks Under $10 Could Make You a Lot of Money

7 Stocks Under $10 Making Big Up Moves

7 Stocks Under $10 to Trade for Big Post-Brexit Gains

5 Stocks Under $10 Set to Soar